An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for AVITA MEDICAL Inc
| Ticker | RCEL |
| FIGI | BBG00TD18T43 |
| CUSIP | 05380C102 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 64 / 0.9% |
| Percentage held by institutional investors | 24.1% |
About
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa (EMEA) and Australia.: 9–10 Wikipedia